| 000 | 00000nam##2200000za#4500 |
| 001 | 9.615750 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210615101253 |
|---|
| 007 | ta |
|---|
| 008 | 150406|2001||||xxc||||| f|0| 0 eng|d |
|---|
| 020 | |a0-662-31030-6 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH13-5/01-1E |
|---|
| 110 | 1 |aCanada.|bHealth Canada. |bInformation, Analysis and Connectivity Branch. |
|---|
| 245 | 10|aPharmacare in Canada: issues and options / |cby Ake Blomqvist, Jing Xu. |
|---|
| 260 | |aOttawa - Ontario : |bHealth Canada. |c2001. |
|---|
| 300 | |avi, 27p. : |breferences ; |c28 cm. |
|---|
| 490 | 1 |aHealth policy working paper series|v01-01 |
|---|
| 500 | |a"This paper, commissioned by Health Canada in December 2000, covers various options for a possible federal initiative in the pharmacare area. The objective at this stage is not to recommend any particular new policy or plan, but rather to outline a variety of options and to identify areas where additional research would be useful as a basis for future policy development."--Introduction. |
|---|
| 546 | |aRésumé en français |
|---|
| 563 | |aSpiral binding |
|---|
| 590 | |a01-45|b2001-11-09 |
|---|
| 690 | 07|aHealth insurance|2gcpds |
|---|
| 690 | 07|aHealth care system|2gcpds |
|---|
| 690 | 07|aDrugs|2gcpds |
|---|
| 720 | 1 |aXu, Jing |
|---|
| 720 | 1 |aBlomqvist, Ake |
|---|
| 775 | 08|tL'Assurance-médicaments au Canada: enjeux et options / |w(CaOODSP)9.625774 |
|---|
| 776 | 0#|tPharmacare in Canada : |w(CaOODSP)9.558002 |
|---|
| 830 | #0|aHealth policy working paper series ;|v01-01|w(CaOODSP)9.514710 |
|---|